
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of 5-HT2B-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosis
Anastasiya Sviridova, Vladimir Rogovskii, В. С. Кудрин, et al.
Journal of Neuroimmunology (2021) Vol. 356, pp. 577608-577608
Closed Access | Times Cited: 15
Anastasiya Sviridova, Vladimir Rogovskii, В. С. Кудрин, et al.
Journal of Neuroimmunology (2021) Vol. 356, pp. 577608-577608
Closed Access | Times Cited: 15
Showing 15 citing articles:
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Lulu Cui, Shu Li, Siman Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 259
Lulu Cui, Shu Li, Siman Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 259
The dual roles of serotonin in antitumor immunity
Yingru Zhang, Yan Wang
Pharmacological Research (2024) Vol. 205, pp. 107255-107255
Open Access | Times Cited: 6
Yingru Zhang, Yan Wang
Pharmacological Research (2024) Vol. 205, pp. 107255-107255
Open Access | Times Cited: 6
Exploring the Role of Neurotransmitters in Multiple Sclerosis: An Expanded Review
Enes Akyüz, Betul Rana Celik, Feyza Şule Aslan, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 4, pp. 527-553
Closed Access | Times Cited: 13
Enes Akyüz, Betul Rana Celik, Feyza Şule Aslan, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 4, pp. 527-553
Closed Access | Times Cited: 13
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis
Teresa Zelante, Giuseppe Paolicelli, Francesca Fallarino, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Teresa Zelante, Giuseppe Paolicelli, Francesca Fallarino, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Th17 Cells, Glucocorticoid Resistance, and Depression
Julia N. Khantakova, Anastasia Mutovina, Kseniya A. Ayriyants, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2749-2749
Open Access | Times Cited: 11
Julia N. Khantakova, Anastasia Mutovina, Kseniya A. Ayriyants, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2749-2749
Open Access | Times Cited: 11
Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue
Gregory Ian Robinson, Dongping Li, Bo Wang, et al.
Life (2023) Vol. 13, Iss. 12, pp. 2345-2345
Open Access | Times Cited: 11
Gregory Ian Robinson, Dongping Li, Bo Wang, et al.
Life (2023) Vol. 13, Iss. 12, pp. 2345-2345
Open Access | Times Cited: 11
Fluoxetine mitigates hypothermia and inflammatory responses in lipopolysaccharide-induced systemic inflammation: Insights into serotonergic and hypothalamic thermoregulatory mechanisms
Isis P Trajano, Luís Henrique Angenendt da Costa, Patrícia Passaglia, et al.
Cytokine (2025) Vol. 189, pp. 156909-156909
Closed Access
Isis P Trajano, Luís Henrique Angenendt da Costa, Patrícia Passaglia, et al.
Cytokine (2025) Vol. 189, pp. 156909-156909
Closed Access
Schizophrenia and neuroinflammation: Pathogenetic and therapeutic aspects
A. V. Chugunov, A A Shmilovich, D. V. Nikolaeva, et al.
(2025) Vol. 27, Iss. 1, pp. 56-63
Closed Access
A. V. Chugunov, A A Shmilovich, D. V. Nikolaeva, et al.
(2025) Vol. 27, Iss. 1, pp. 56-63
Closed Access
Th17-cells in depression: Implication in multiple sclerosis
Mikhail Melnikov, Anna Lopatina
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Mikhail Melnikov, Anna Lopatina
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy
Sudhir K. Yadav, Kouichi Ito, Suhayl Dhib‐Jalbut
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14756-14756
Open Access | Times Cited: 10
Sudhir K. Yadav, Kouichi Ito, Suhayl Dhib‐Jalbut
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14756-14756
Open Access | Times Cited: 10
The Dual Role of the β2-Adrenoreceptor in the Modulation of IL-17 and IFN-γ Production by T Cells in Multiple Sclerosis
Mikhail Melnikov, Vladimir Rogovskii, Anastasiya Sviridova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 668-668
Open Access | Times Cited: 12
Mikhail Melnikov, Vladimir Rogovskii, Anastasiya Sviridova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 668-668
Open Access | Times Cited: 12
Targeting 5-HT Is a Potential Therapeutic Strategy for Neurodegenerative Diseases
Cencan Xing, Hongyu Chen, Wangyu Bi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13446-13446
Open Access | Times Cited: 2
Cencan Xing, Hongyu Chen, Wangyu Bi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13446-13446
Open Access | Times Cited: 2
Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapy
Mikhail Melnikov, D. S. Kasatkin, Anna Lopatina, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 8
Mikhail Melnikov, D. S. Kasatkin, Anna Lopatina, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 8
The Role of D2-like Dopaminergic Receptor in Dopamine-mediated Modulation of Th17-cells in Multiple Sclerosis
Mikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 8, pp. 1632-1639
Open Access | Times Cited: 6
Mikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 8, pp. 1632-1639
Open Access | Times Cited: 6
T Lymphocyte Serotonin 5-HT7 Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients
Flora Reverchon, Colleen Guillard, Lucile Mollet, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2418-2418
Open Access | Times Cited: 4
Flora Reverchon, Colleen Guillard, Lucile Mollet, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2418-2418
Open Access | Times Cited: 4